!"#$%&"'(")*+,*

!"#$%&'(%)*+,(

-./012( 34( '56.7/3( 839( :;<( =>?>(

5<@<(.4(A/<B356<(83( C2D343-(5/3E

:61D<-( @3F15:4<-( 5<4( G</@:5124(

E

:963/4:61D<-(83(3FA/3-124H

I:(A/3A:/:5124(3-(9:(7:-3(83(4.3-E

6/<(6/:7:C<(B(9:(144<D:5124(4.3-6/<(

@381<(A:/:(5/3:/H

81-3;:@<-( 5<4( 7:-3( :( 9:-( 4353-1E

E

@<-(3FA/3-:/(5<4( 1@:0343-( 9<(J.3(

.-638(J.13/3(A:/:(-.(3@A/3-:H

K.3/3@<-(J.3( ( -.(430<51<(5/3L5:(

10.:9(J.3(39(4.3-6/<H(M<-(14D9<5.5/:E

@<-(:9(?>>N(5<4(-.-(5/33451:-(A:/:(

9<((J.3(.-638(J.13/3(3FA/3-:/H

K.1343-("<@<-

O1-124

P1-124

P:9</3-

Q19<-<GR:

S</A</51<4:/(.4(-3/D151<(83(81-3;<(0/TE

:(6<8<-(4.3-6/<-(5913463-H

M.3-6/<-(3-G.3/L<-(3-6:4(</1346:8<-(:(

J.3(4.3-6/<-(5913463-(6340:4( 9:(@3C</(

9:(5<@A363451:H

5<@A36161D<(34(39(@3/5:8<(@3F15:4<(3(14E

63/4:51<4:9(5:A:L(83(8:/(-<9.51243-(:(9:-(

BU<(A.791516:/1:-(83(4.3-6/<-(5913463-H

!9(6/:7:C<(4<-(V:/T(917/3-H

W0@:19H5<@

"3/D151<-

I<0<61A<

S:A393/1:X

((Y<C:(@3@7/36:8:

((#:/C36:(83(A/3-346:5124

((Q:56./:-

((!61J.36:-

(("<7/3-

((Q<983/

Z/383451:9U[:G363-

&@:43-(S.791516:/1<

&4D16:51<43-("<51:93-

Z:/639U*:443/US34824

Z:9348:/1<

S<-6:9

#/RA615<U%RA615<

((

P<9:463UQ9B3/

I<4:-

S</6:8:(83(I17/<

,4.451<-(A:/:(@381<-(&@A/3-<-

Z/3:5124(83(-161<(\37

,41@:5124

O:J.36:(D1/6.:9(B(]%

S/3-346:51<43-(5<4(:41@:5124

"<9.51<43-(14630/:93-(83(1@A/3-124

'GG-36

"3/10/:GR:

&@A/3-124(%1016:9

&@A/3-124(83(0/:4(G</@:6<

%&"!^'(%&[&#,I

Q<6<0/:GR:

O:63/1:9(S.791516:/R<

&@A/3-124

8_7L:H5/3:61D<-

Z<46:@<-(5<4(3-6.81<(G<6<0/TG15<(

A:/:(G<6<0/:GR:(83(A/<8.56<(B(3J.1A<(

A:/:(-3-1<43-(34(3D346<-(<(3@A/3-:-H

,/6R5.9<-(A/<@<51<4:93-

O:63/1:9(S'S

*#I

AMISTAD DESARROLLO Y COOPERACIÓN A.C.

Elite Medical Care

`` H̀8_7L:`37H5<@

] =

?

*18834(a<B

?HEZ.:8/<-(

((((%35</:61D<-

=HEP<9:463

]HE#:/C36:(83(

((((S/3-346:5124

3-6.81<8_7L:WV<6@:19H5<@

!-6:-( -<4( :90.4:-( 3@A/3-:-( 5<4(

9:-(J.3(V3@<-(6/:7:C:8<

83( G</@:(81/356:(B( 9:-( 5.:93-(V:4(

-18<(A:/63(839(83-:/<99<(83(4.3-6/<(

3-6.81<H

#<@:48<( 34( 5.346:( J.3( 5:8:( 591E

3463(61343(4353-18:83-(83(5<@.E

415:5124(81G3/3463-(4<-(81@<-(:(9:(

6:/3:(83(81-3;:/(5<4G</@3(:9(5:-<(

A:/:(5/3:/(1834618:8(D1-.:9H

"<9<(39(?>N(83(9<-(430<51<-(613434(

183:(83(9<(1@A</6:463(J.3(3-(9:(1@E

:034(A:/:(39(3F16<(3(1@A:56<(D1-.:9H(

EI'['#&S'

Z913463-

?

]

b

c

=

?HEI<0<

=HE!61J.36:

]HE#:/C36:(83

(((S/3-346:5124

cHE*9<5_(83(M<6:-

bHEQ:56./:

c

= ?

]

b

Z<:69

?HEI<0<61A<

=HE,4.451<(A:/:

((((!-A356:5.9:/

]HEZ:9348:/1<

cHE,4.451<(A:/:

bHE#:/C36:(83

((((S/3-346:5124

! "

# $

%

&'()*+,*-(./'+0/1*

!234/15*)/+-*+++61*7*8)/.(98"236:7)/'#23;:5/+++++,*<=1*)/-/

%23&7)/<>/

!

"

?6,

!234/15*)/7+-*+++61*7*8)/.(98"236/@(8/7+A*=

? ]

=

P:/1<-

?HES<-6:9

=HE#/1A615<

]HES:014:(\37

]

= ?

c

P:/1<-

?HEO:46:-

=HEZ:9348:/1<

cHE#:/C36:-(83

((((S/3-346:5124

Z'M#,Z#'

#39HX(bdbeEbcce(Z39HXbb?]]eE>fd>(U(bbccedEe]>?

O:19X(3-6.81<8_7L:WV<6@:19H5<@(U(8_7L:H5/3:61D<-W0@:19H5<@

`` H̀8_7L:`37H5<@